Co-Diagnostics CODX
NASDAQ CODX
$0.56 -0.08 (-12.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Co-Diagnostics (CODX) Non-Current Deffered Revenue (2017 - 2018)

Updated

Co-Diagnostics' Non-Current Deffered Revenue was $126,066 in Q3 2018, down 32.3% from $186,144 a year earlier and down 7.1% from the prior quarter.

Analysis

Co-Diagnostics (CODX) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

At the end of FY2017, Non-Current Deffered Revenue at Co-Diagnostics came in at $183,546.

  • Per Business Quant data, CODX's Non-Current Deffered Revenue in the three quarters before Q3 2018 was $135,762 (Q2 2018), $145,458 (Q1 2018) and $183,546 (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn -
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn -
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn -
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn -
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn -
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn -
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn -
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn -
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn -
10 Co-Diagnostics 2.41 Mn -37.93 Mn 120,828.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 126,066.00
Jun 30, 2018 135,762.00
Mar 31, 2018 145,458.00
Dec 31, 2017 183,546.00
Sep 30, 2017 186,144.00
Jun 30, 2017 188,742.00
API Access

Co-Diagnostics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CODX&period=max&api_key=YOUR_API_KEY